Publications by authors named "M Uzzan"

Claim this Profile
A
Associations of advanced therapies in inflammatory bowel diseases.
M Uzzan, M Barrau, X Roblin

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.
Aurélien Amiot, Julien Kirchgesner, Hadrien Alric, Xavier Tréton, Mathieu Uzzan

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease.
Zlata Chkolnaia, Benedicte Lebrun-Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Tommaso Innocenti, Jurij Hanžel, Marie Truyens, Milan Lukaš, Hannah Gordon, Mathieu Uzzan

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohort.
Camille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, Sophie Hue, Pierre Wolkenstein, Mathieu Uzzan

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis